Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMAB008 vs Remicade PK in Healthy Male Volunteers
CTR20230748Phase 4Completed
- Sponsor
- MabPlex
- Start
- Mar 2023
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab-axxq in rheumatoid arthritis (RA), sponsored by MabPlex. Started Mar 2023; status: completed.
02
Drugs
infliximab-axxq
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20230748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230748.